EUVIMEDDescoperă EUVIMED
Video/Audio

Predicting and Validating the Regulation of Podocyte Injury and Treatment of Diabetic Kidney Disease by Yinhuo Tang

Shukun Chen, Chunyan Liu, Yan He, Tingting Zhao, Shuang Yu, Zhaoman Wang, Chunhua He, Fan Li, Sichao Ma, Shoulin Zhang

Journal of Visualized Experiments · 2025

DOI: 10.3791/67939 ↗

At a glance

Video/Audio in Journal of Visualized Experiments, 2025. Written by Shukun Chen and 9 co-authors. Institution: Nephropathy Department, the Affiliated Hospital to Changchun University of Chinese Medicine. Major MEDLINE topics: Podocytes, Diabetic Nephropathies, Drugs, Chinese Herbal. Cited 1 times so far (Crossref); 52 references.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Diabetic kidney disease (DKD) is a chronic kidney disease characterized by massive proteinuria and decreased glomerular filtration rate. The main pathological feature of DKD is renal microangiopathy, and ~40% of diabetic patients will develop DKD. The podocyte-associated proteins CD2AP and WT-1 play a crucial role in maintaining the normal function of podocytes and the integrity of the glomerular filtration barrier. When podocyte structure or function is disrupted-due to inflammation, oxidative stress, or other pathological insults-the slit diaphragm and actin cytoskeleton are damaged, leading to increased permeability of the glomerular filtration barrier and resulting in proteinuria. Yinhuo Tang (YHT) is a traditional Chinese medicine prescription that has the function of reducing proteinuria and delaying the deterioration of renal function; however, the mechanism of YHT in treating DKD is not clear. In this paper, based on network pharmacology and animal experiments, we examined the blood glucose, liver function, renal function, blood lipids, renal pathology, expression levels of podocyte marker proteins CD2AP and WT-1, as well as the PI3K/AKT/NF-κB signaling pathway in db/db mice after the administration of YHT for 8 weeks. Our results show that YHT reduces the expression levels of inflammatory factors by inhibiting the PI3K/AKT/NF-κB signaling pathway, thus reducing podocyte damage to play a role in delaying the progression of DKD.

Subjects

MeSH terms (MEDLINE)

PodocytesDiabetic NephropathiesDrugs, Chinese HerbalAnimalsMiceMice, Inbred C57BLMaleCytoskeletal ProteinsAdaptor Proteins, Signal TransducingWT1 Proteins

Substances

Drugs, Chinese HerbalCD2-associated proteinCytoskeletal ProteinsAdaptor Proteins, Signal TransducingWT1 Proteins

Authors and institutions

  • Nephropathy Department, the Affiliated Hospital to Changchun University of Chinese Medicine.
  • College of Integrated Chinese and Western Medicine, Changchun University of Chinese Medicine.
  • Nephropathy Department, the Affiliated Hospital to Changchun University of Chinese Medicine; 632962419@qq.com.
  • Nephropathy Department, the Affiliated Hospital to Changchun University of Chinese Medicine; shoulin-z@163.com.

Cite

APA

Chen, S., Liu, C., He, Y., Zhao, T., Yu, S., Wang, Z., He, C., Li, F., Ma, S., & Zhang, S. (2025). Predicting and Validating the Regulation of Podocyte Injury and Treatment of Diabetic Kidney Disease by Yinhuo Tang. Journal of Visualized Experiments. https://doi.org/10.3791/67939

Vancouver

Chen S, Liu C, He Y, Zhao T, Yu S, Wang Z, et al. Predicting and Validating the Regulation of Podocyte Injury and Treatment of Diabetic Kidney Disease by Yinhuo Tang. Journal of Visualized Experiments. 2025. doi:10.3791/67939

BibTeX
@article{Chen2025,
  author = {Chen, Shukun and Liu, Chunyan and He, Yan and Zhao, Tingting and Yu, Shuang and Wang, Zhaoman and He, Chunhua and Li, Fan and Ma, Sichao and Zhang, Shoulin},
  title = {Predicting and Validating the Regulation of Podocyte Injury and Treatment of Diabetic Kidney Disease by Yinhuo Tang},
  journal = {Journal of Visualized Experiments},
  year = {2025},
  doi = {10.3791/67939}
}
Start for free →